Multiplex Technology
A clear answer for complex immunobiological questions
InfYnity Biomarkers has acquired a high-end specialization in the multiplex technology and the development of multiplex ELISA immunoassays allowing simultaneous detection of antibodies against a set of selective and validated antigens of a blood sample. These tests are very innovative because they allow to read serological signatures in patients and can therefore provide highly relevant clinical information.
The Multiplex technology opens the door to many high-profile applications ranging from developing multi-parametric immunoassays to selecting reactive antigens and screening for relevant Biomarkers of a given disease and monitoring therapy or vaccine efficacy.
Multi-SARS-CoV-2 Kit
Multi-SARS-CoV-2 test is a high resolution in-vitro diagnostic Multiplex ELISA assay (RUO) which enables simultaneous detection of anti-SARS-CoV-2 antibodies to a set of selective and validated antigens.
Multi-Cruzi Kit
The Multi-Cruzi test is a high resolution in-vitro diagnostic Multiplex ELISA assay (RUO) which permits the simultaneous detection and identification of anti-T. cruzi antibodies directed against 15 different T. cruzi antigen specificities.
Multi-HTLV Kit
Multi-HTLV is a novel high-resolution Multiplex ELISA assay (RUO) for the confirmation and discrimination of Human T-cell Lymphotropic Virus type I (HTLV-I) and type II (HTLV-II) infections, by antibodies detection in human serum or plasma.